5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142315, 514443, 544 59, 549 50, C07D29512, C07D26530, C07D49502

Patent

active

049295497

ABSTRACT:
Novel 5-carbamoylthieno[2,3-b]thiophene-2-sulfonamides and derivatives thereof are prepared in reactions of 5-methoxycarbonylthieno-[2,3-b]thiophene-2-sulfonamide with alkylamines, alkoxyalkylamines and hydroxyalkylamines. These compounds are useful for the treatment of elevated intraocular pressure in compositions including ophthalmic drops and inserts.

REFERENCES:
patent: 3733322 (1973-05-01), Wright, Jr.
patent: 4386098 (1983-05-01), Woltersdorf et al.
patent: 4416890 (1983-11-01), Woltersdorf et al.
patent: 4426388 (1984-01-01), Woltersdorf et al.
patent: 4668697 (1987-05-01), Shepard et al.
patent: 4677115 (1987-06-01), Baldwin et al.
patent: 4798831 (1989-01-01), Prugh et al.
patent: 4806562 (1989-02-01), Hartman et al.
Hartough, Chemistry of Heterocycles, Thiophene Interscience Publishers, New York, 1952, pp. 418-419.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically a will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-520475

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.